Answers are grounded in this paper and cite their sources.
We read with interest the article entitled “Evaluation of the clinical outcome of hypercalcemia of malignancy and concurrent azotemia in dogs with lymphoma” by Strumpf et al. and question the validity of some of their conclusions. First, the support for a diagnosis of acute kidney injury (AKI) could have been stronger. Markers of AKI, such as urinary cystatin B or neutrophil gelatinase (NGAL), were not evaluated, given that the study was retrospective in nature. The authors stated that they performed urinalysis in all dogs, yet they only provided urine specific gravity (USG) results. Microscopic evaluation of urine sediment should also have been reported, primarily to identify markers of AKI, such as cylindruria (eg, hyaline casts, granular casts, renal tubular cell casts) in addition to documentation of free renal tubular epithelial cells. Proteinuria evaluated by dipstrip urine chemistry was not reported either. It is likely that the magnitude of dipstrip proteinuria would be low, because USG was quite low in most of the dogs at presentation. Acute kidney injury sometimes can be associated with increased urinary protein-to-creatinine ratio (UPC) and microalbuminuria (MA). It would have been interesting and perhaps valuable to have evaluated proteinuria in a more robust way. Increased UPC may be seen with renal tubular damage and less tubular absorption of small molecular weight proteins. Some types of AKI also result in increased MA because of decreases in proximal tubular reabsorption of albumin. Second, the authors could have discussed the potential adverse effects of hypercalcemia on renal tubular function in more depth. It is true that hypercalcemia impairs the effect of antidiuretic hormone (ADH) on the collecting tubules by a variety of mechanisms. Acute tubular injury (necrosis or degeneration) could also impair the urinary concentrating mechanism in other tubular locations. Although parathyroid hormone-related peptide (PTHrP) is usually considered to be the major mediator of hypercalcemia of malignancy in dogs,1 PTHrP does not appear to be sufficient by itself to be the mediator of hypercalcemia in dogs with lymphoma, as it appears to be in dogs with hypercalcemia associated with anal sac adenocarcinoma. Other mediators of hypercalcemia in dogs (and people) with lymphoma exist in addition to PTHrP.1 Unfortunately, serum or plasma concentrations of PTHrP were not reported in the study. Readers would have benefitted from additional discussion about the possible mechanisms for hyposthenuira, isosthenuria, and submaximally concentrated urine associated with nephrogenic diabetes insipidus (NDI) in the face of hypercalcemia. These mechanisms include decreased binding between ADH and the V-2R receptor in the collecting tubules, as well as decreased expression of aquaporin-2 (AQP2) needed for reabsorption of water.2-4 Dogs with NDI cannot concentrate their urine, an effect that is particularly inappropriate when they are dehydrated. Over 72% of the dogs (21/29) in the study had USG ≤1.012; 9 of those dogs (31%) had hyposthenuric urine, thus supporting this mechanism. In our clinical experience, when dogs develop polyuria and polydipsia, the response of most owners is to limit water intake. This is even more likely when dogs are vomiting. The authors did not report how many dogs presented with vomiting, although they did mention vomiting as 1 of the presenting clinical signs. Therefore, the more likely scenario is that the majority of the dogs reported in this study had either prerenal azotemia, or at least a major component of the azotemia was prerenal and was corrected by eliminating the cause of the hypercalcemia (ie, chemotherapy for lymphoma) and using appropriate fluid therapy. The authors did not discuss what type and volume of fluids were used. It is common in our clinical experience for hypercalcemic dogs to receive insufficient fluid volume to replenish the intravascular and interstitial compartments. In these instances, even volumes of fluid administered at “twice maintenance” or “3 times maintenance” can result in weight loss because urine volume can remain quite high until after normocalcemia has been restored in some dogs. Consequently, some extracellular fluid volume contraction and prerenal azotemia will remain. Although we lack sufficient data from large studies, our clinical impression is that if lymphoma is treated and fluid imbalance is corrected, most affected dogs will recover. Acute kidney injury leading directly to death is extremely uncommon in this subset of patients, as shown in this study, but chronic kidney disease (CKD) may develop in some patients. The authors could have provided more evidence to convince the reader that most of the dogs in the study had intrinsic AKI during the early phase of evaluation. The fact that azotemia resolved in only 2 of 29 dogs after 10 days does support the contention of intrinsic AKI or underlying CKD unless fluid volume administration was insufficient and lingering prerenal azotemia existed in some dogs. The major conclusion that hypercalcemia resolved in all dogs by 24 days and azotemia resolved in 12 of 29 dogs at the same time still is important information.
No takes yet. Share an insight, caveat, or question.
Couto et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: